Alport syndrome associated with diffuse leiomyomatosis: COL4A5-COL4A6 deletion associated with a mild form of Alport nephropathy
Henning Mothes1,,
Laurence Heidet2,
Christelle Arrondel2,
Konrad Klaus Richter1,
Mariana Thiele1,
Ludwig Patzer3,
Yoshikazu Sado4,
Marie-Claire Gubler2,
Corinne Antignac2 and
Johannes Scheele1
1 Department of General and Visceral Surgery, Friedrich-Schiller-University Jena, Germany,
2 INSERM U423, Université René Descartes, Hopital Necker, Paris, France,
3 Department of Pediatrics, University Hospital Jena, Germany and
4 Division of Immunology, Shigei Medical Research Institute, Okayama, Japan
 |
Abstract
|
---|
Background. The X-linked Alport syndrome (AS) is an inherited nephropathy due to mutations in the COL4A5 gene, encoding the
5 chain of type IV collagen, a major component of the glomerular basement membrane (GBM). Here, we report a new kindred with the rare association of X-linked AS and diffuse leiomyomatosis (DL), which is a tumourous process involving smooth muscle cells of the oesophagus, the tracheobronchial tree and, in females, the genital tract. For this syndrome, an almost constant association of large COL4A5 rearrangements with a severe juvenile form of nephropathy has been described for male patients.
Methods. DNA rearrangement at the COL4A5-COL4A6 locus was studied in several members of this family using polymerase chain reaction and pulsed field gel electrophoresis. Furthermore, immunohistochemical staining of tumour and skin samples was performed.
Results. The affected patients in this family carry a 120 kb deletion by which the COL4A5 exon 1 and COL4A6 exons 1, 1', and 2 are removed. Immunohistochemical investigation of a skin biopsy of an affected male patient confirmed the absence of both the
5 and the
6 chains of type IV collagen in the basement membrane of the skin. Surprisingly, both affected male patients had a rather mild renal phenotype.
Conclusions. This report shows that, contrary to what has been reported to date, patients suffering from AS associated with DL can be associated with a late onset renal failure (adult) form of nephropathy.
Keywords: adult type nephropathy; Alport syndrome; COL4A5-COL4A6 deletion; diffuse leiomyomatosis; DNA analysis
 |
Introduction
|
---|
Alport syndrome (AS) is an inherited nephropathy progressing to end-stage renal failure (ESRF), often associated with high-tone sensorineural deafness and specific eye signs (anterior lenticonus and macular flecks). It is characterized by abnormalities of the glomerular basement membrane (GBM) (thinning, thickening, and splitting) shown by electron microscopy. AS is due to mutations in one of three chains of type IV collagen that are highly expressed in the GBM:
3,
4, and
5(IV) [1]. These chains are encoded by three genes: COL4A3 and COL4A4 which are located head-to-head on chromosome 2 [2], and COL4A5 which is located on the long arm of the X chromosome, head-to-head with another type IV collagen gene, COL4A6. The latter encodes the
6(IV) chain that is not expressed in the GBM. Mutations of the COL4A5 gene, encoding the
5 chain of type IV collagen, are responsible for the most common (85%), X-linked form of the disease. In a few families, X-linked AS is associated with diffuse leiomyomatosis (DL), a tumourous process involving smooth muscle cells of the oesophageal wall, the tracheo-bronchial tree and, in females, the genital tract. A remarkable feature of AS associated with DL is a very severe nephropathy in males, rapidly progressing to ESRF early in life [38]. This is in agreement with the molecular defect underlying this association, resulting in null mutation of COL4A5 due to deletions removing the 5'-end of both the COL4A5 and COL4A6 genes.
In this paper we describe a new family affected by the DL-AS association. All affected individuals showed constitutional deletions removing the 5'-ends of COL4A5 and COL4A6. Surprisingly, both affected males in this family had a mild form of AS nephropathy.
 |
Subjects and methods
|
---|
Patients
We have assessed a Caucasian family with a history of nephropathy and oesophageal tumours, showing an X-chromosomal inheritance pattern (Figure 1
). The clinical features could be traced back to the grandfather of the two index patients (patients 4 and 5 in Figure 1
), who were operated at our hospital and provided the tissue samples for histological analysis in this study.
Their grandfather (patient 1) apparently suffered from dysphagia almost throughout his life. He died of renal failure aged 50. His daughter, the mother of the two index patients (patient 3), underwent surgery for an oesophageal tumour at the age of 30 after a 15 year history of dysphagia. No renal disease, visual, or hearing problems had been reported for her. Her son (patient 4) had an oesophageal resection of a histologically proven leiomyoma aged 13. Nine years later a tumour recurrence at the site of anastomosis was excized. He additionally suffered from hypoacusis and was operated for bilateral cataracts. At the age of 40 he presented to our department with a second recurrence of his leiomyoma at the oesophagogastric anastomosis. Laboratory studies revealed a serum creatinine of 1.3 mg/dl and a creatinine clearance at 111 ml/min. A 8x5 cm sized solid tumour was detected with a contrast X-ray study and by CT-scan, and was then successfully enucleated in our hospital.
The 34-year-old sister (patient 5) reported a 20-year history of progressive dysphagia and heartburn on presentation. A CT-scan showed an 18x4 cm sized leiomyoma that caused a narrowing and shifting of the oesophagus as well as dystelectases of the right lung. Furthermore, an adenoma of the left adrenal gland, and hypertrophy of the clitoris were detected. She did not show any visual or hearing problems. Urinary and blood analysis revealed microhaematuria and proteinuria (350 mg/dl), a normal creatinine clearance (192 ml/min), and serum creatinine (0.57 mg/dl). The oesophageal tumour was excized by subtotal oesophagectomy followed by reconstructive colonic interposition. She was discharged without any symptoms.
Three of four daughters of patients 4 and 5 (patients 68) showed microhaematuria with normal renal function. Because of dysphagia all three of them had gastroscopy: patient 6 had already developed a 8x8 cm sized tumour of the lower oesophageal wall, patient 7 showed several small lesions, and patient 8 had a 3x2 cm sized solid tumour of the lower oesophagus. Patient 9 was not investigated because she was asymptomatic and still very young. After informed consent, blood samples were collected from six members of the family (patients 4, 5, 6, 7, 8, and 9).
Tissues and immunohistochemical analysis
Specimens of the oesophageal tumours were obtained from patients 4 and 5. Part of the tissue including a skin biopsy of patient 4, was snap-frozen in liquid nitrogen immediately after removal and stored at -70°C. A representative section was cut from each tumour, fixed in formaldehyde, embedded in paraffin, and subjected to standard histopathological investigation. Further histochemical evaluation was performed to detect differentiated myogenic cells (alpha-smooth-muscle actin (ASMA); pan-muscle-specific actin (HHF 35)) and Schwann-cells (S-100 protein).
Immunohistochemical staining of the skin sample was done as previously described [9] using monoclonal antibodies recognizing the NC1 domain of the alpha 1 (MAB1, Wieslab AB, Lund, Sweden), the alpha 5 (MabA7, a gift from M. Kleppel [10], or of the alpha 6 chain (Mab H63, [11]).
DNA analysis
High-molecular-weight genomic DNA was prepared for pulsed field gel electrophoresis (PFGE) analysis from peripheral lymphocytes as described previously [5]. DNA was digested with NotI, NruI, SalI, and SfiI restriction enzymes, separated by PFGE, followed by hybridization with the appropriate DNA probes [5]. The probes used have been reported elsewhere: JZ4 and Pc4b are encoding the 5'- and the 3'-end of COL4A5 cDNA [12,13], respectively, and JZ3 is encoding the 5'-end of COL4A6 cDNA [14].
For polymerase chain reaction (PCR) analysis, DNA was extracted from peripheral blood leucocytes by a standard procedure. PCR amplification and agarose gel electrophoresis were carried out as previously described [5]. Primer sequences and annealing temperature are listed in Table 1
. All PCR reactions were performed with 30 cycles of denaturation at 94°C for 1 min, annealing at various temperatures (Table 1
) for 1 min, and with extension at 72°C for 1 min.
 |
Results
|
---|
Histopathology
Histopathology of the resected oesophageal tumour of patient 4 showed spindle-shaped cells, formed in groups with nodular structures. Cells showed eosinophilic fibrillar cytoplasm and spindle-shaped nuclei. Neither mitosis nor higher-grade cell atypias were seen. Histological findings were consistent with the diagnosis of leiomyoma without malignant transformation. The resected oesophageal tumour of patient 5 showed similar findings, leading to identical diagnosis.
DNA analysis
In patient 4, we first studied DNA rearrangements using PCR amplification of genomic DNA. No amplification products were observed using primers flanking COL4A5 exon 1 (Figure 2
), or a couple of primers located in COL4A6 exon 1 and COL4A6 exon 2, respectively. Conversely, COL4A6 exon 3 and the marker 909L (located in COL4A6 intron 3 [3]) were amplified. The same applies for primers amplifying the E7M13 marker located within COL4A6 intron 2 [3] that was not deleted in this patient.

View larger version (120K):
[in this window]
[in a new window]
|
Fig. 2. Blood PCR products from genomic DNAs from five females and one male from a DL-AS family (individuals are numbered according to Figure 1 ) and one control DNA (C). Size=195 kb.
|
|
High-molecular-weight DNAs from six family members were analysed by PFGE. The Pc4b and JZ3 probes were hybridizing the same 830-kb NotI and 530-kb NruI junction fragments in male and female patients (Figure 3
). Affected females also displayed normal sized restriction fragments (950 and 650 kb with NotI and NruI, respectively), whereas the control and the non-affected female (patient 9) only showed the normal fragment. All affected patients displayed a 60-kb SfiI junction fragment hybridizing the JZ4 probe (not shown). According to the map of the region, these results indicate a deletion of about 120 kb (Figure 4
) removing COL4A5 exon 1, the intergenic region, and COL4A6 exons 1', 1, and 2.

View larger version (67K):
[in this window]
[in a new window]
|
Fig. 3. Analysis of restriction fragment pattern found in individuals 4, 6, 9, and 7 and in a control (C) using PFGE. Autoradiogram of NruI (A) and NotI (B) digested DNAs hybridized with Pc4b. Sizes indicated are in kilobases.
|
|

View larger version (8K):
[in this window]
[in a new window]
|
Fig. 4. (A) Restriction map of the COL4A5/COL4A6 locus. Location of the cDNA probes (horizontal bars) and of the first exons (numbered vertical bars) are indicated. (B) Schematic representation of the deletions observed. Open boxes=deletion; hatched boxes=potential breakpoint region; black boxes=no deletion.
|
|
Immunohistochemical analysis
The histochemical staining of the tumour samples showed a positive reaction for ASMA and HHF35, but no reactivity for S-100. The skin biopsy, taken from patient 4, showed normal
1(IV) chain immunoreactivity. There was, however, no immunoreactivity for
5 and
5(IV) chains in the basal membrane (not shown).
 |
Discussion
|
---|
In the present paper we studied DNA rearrangements in a family affected by the DL-AS association. Using PFGE and PCR analysis of genomic DNA, we showed that affected members of this family carry a 120 kb COL4A5-COL4A6 deletion removing COL4A5 exon 1 and COL4A6 exons 1, 1', and 2. This is in agreement with previous studies, which have shown that the extent of the deletions in COL4A6 in DL-AS patients is consistently confined to the first two exons of the gene [3,5,6], whereas patients with deletions extending further than COL4A6 exon 3 are not DL affected [5,7]. This reinforces the hypothesis that COL4A6 intron 2 contains unidentified crucial sequences involved in the regulation of smooth-muscle proliferation.
In X-linked AS, affected males develop ESRF at ages that vary widely from kindred to kindred, but run broadly through within a kindred. According to the severity of nephropathy, families can be classified in juvenile (age of ESRF in males <31 years) or adult (age >31) kindreds. Considering the many mutations identified in the COL4A5 gene, we [15], and others [16], have previously reported the almost constant association of large COL4A5 rearrangements with severe juvenile form of AS. Accordingly, in the DL-AS association, except of one case [17], all affected males reported to date [reviewed in 6,7] were suffering from a severe nephropathy. This is consistent with deletions observed in DL-AS patients, that are expected to lead to a complete absence of COL4A5 expression.
Surprisingly, in the DL-AS family we report here, both male patients did not present with renal failure at the ages of 40 and 50, respectively. DNA rearrangement analysis in this family showed COL4A5-COL4A6 deletions, which surely result into absence of the
5 chain of type IV collagen in GBM in affected male patients. Accordingly, immunohistochemical analysis of a skin biopsy of patient 4 showed no
5(IV) expression in the skin basement membrane. Both PFGE and PCR analysis strongly suggest that the deletions in this family were not associated with other types of complex rearrangements, such as duplication or inversion, which could have explained a rather mild kidney phenotype in males. Furthermore, the mutation was clearly inherited from patient 1, ruling out the possibility of a somatic mosaicism in patient 4, which has been previously reported in a DL-AS patient [8] and could have led to a less severe kidney disease.
We show that, similar to some COL4A5 point mutations, large deletions of the gene can result in the adult form of AS nephropathy. Whether other gene(s) may be implicated in determining the severity of the renal phenotype in COL4A5 null mutations remains to be examined. Our results indicate that the phenotypic expression of the renal disease in AS associated with DL is not only determined by the type of mutation, but also depends on other yet unknown mechanisms.
 |
Notes
|
---|
Correspondence and offprint requests to: Dr Henning Mothes, Klinik für Chirurgie, Friedrich-Schiller-Universität Jena, Bachstrasse 18, D-07740 Jena, Germany. Email: Henning.mothes{at}med.uni\|[hyphen]\|jena.de 
 |
References
|
---|
-
Mochizuki T, Lemmink HH, Mariyama M et al. Identification of mutations in the alpha3(IV) and alpha4(IV) collagen genes in autosomal recessive Alport syndrome. Nature Genet1994; 8: 7782[ISI][Medline]
-
Mariyama M, Zheng K, Yang-Feng TL, Reeders ST. Colocalization of the genes for the alpha3(IV) and alpha4(IV) chains of type IV collagen to chromosome 2 bands q35-q37. Genomics1992; 13: 809813[ISI][Medline]
-
Zhou J, Mochizuki T, Smeets H et al. Deletion of the paired alpha 5(IV) and alpha 6(IV) collagen genes in inherited smooth muscle tumors. Science1993; 261: 11671169[ISI][Medline]
-
Antignac C, Zhou J, Sanak M et al. Alport syndrome and diffuse leiomyomatosis: deletions in the 5' end of the COL4A5 collagen gene. Kidney Int1992; 42: 11781183[ISI][Medline]
-
Heidet L, Dahan K, Zhou J et al. Deletions of both alpha 5 (IV) and alpha 6 (IV) collagen genes in Alport syndrome and in Alport syndrome associated with smooth muscle tumours. Hum Mol Genet1995; 4: 99108[Abstract]
-
Antignac C, Heidet L. Mutations in Alport syndrome associated with diffuse esophageal leiomyomatosis. In: Tryggvason K, ed. Molecular Pathology and Genetics of Alport Syndrome. Contributions in Nephrololgy. Karger, Basel, 1996; 117: 172182
-
Heidet L, Cohen-Solal L, Boye E et al. Novel COL4A5/COL4A6 deletions and further characterization of the diffuse leiomyomatosis-Alport syndrome (DL-AS) locus define the DL critical region. Cytogenet Cell Genet1997; 78: 240246[ISI][Medline]
-
Ueki Y, Naito I, Oohashi T et al. Topoisomerase I and II consensus sequences in a 17-kb deletion junction of the COL4A5 and COL4A6 genes and immunohistochemical analysis of esophageal leiomyomatosis associated with Alport syndrome. Am J Hum Genet1998; 62: 253261[ISI][Medline]
-
Gubler MC, Knebelmann B, Beziau A et al. Autosomal recessive Alport syndrome: immunohistochemical study of type IV collagen chain distribution. Kidney Int1995; 47: 11421147[ISI][Medline]
-
Kleppel MM, Fan WW, Cheong HI, Kashtan CE, Michael AF. Immunochemical studies of the Alport antigen. Kidney Int1992; 41: 16291637[ISI][Medline]
-
Ninomiya Y, Kagawa M, Iyama K et al. Differential expression of two basement membrane collagen genes, COL4A6 and COL4A5, demonstrated by immunofluorescence staining using peptide-specific monoclonal antibodies. J Cell Biol1995; 130: 12191229[Abstract]
-
Zhou J, Hertz JM, Leinonen A, Tryggvason K. Complete amino acid sequence of the human alpha 5(IV) collagen chain and identification of a single-base mutation in exon 23 converting glycine 521 in the collagenous domain to cysteine in an Alport syndrome patient. J Biol Chem1992; 267: 1247512481[Abstract/Free Full Text]
-
Hostikka SL, Eddy RL, Byers MG, Hoyhtya M, Shows TB, Tryggvason K. Identification of a distinct type IV collagen alpha chain with restricted kidney distribution and assignment of its gene to the locus of X-chromosome-linked Alport syndrome. Proc Natl Acad Sci USA1990; 87: 16061610[Abstract]
-
Zhou J, Ding M, Zhao Z, Reeders ST. Complete primary structure of the sixth chain of human basement membrane collagen, alpha 6(IV). J Biol Chem1994; 269: 1319313199[Abstract/Free Full Text]
-
Knebelmann B, Breillat C, Forestier L et al. Spectrum of mutations in the COL4A5 collagen gene in X-linked Alport syndrome. Am J Hum Genet1996; 59: 12211232[ISI][Medline]
-
Lemmink HH, Schröder CH, Monnens LAH, Smeets HJM. The clinical spectrum of type IV collagen mutations. Hum Mutat1997; 9: 477499[ISI][Medline]
-
Thorner P, Heidet L, Moreno-Merlo F, Edwards V, Antignac C, Gubler MC. Diffuse leiomyomatosis of the esophagus: disorder of cell-matrix interaction? Pediatr Dev Pathol1998; 1: 543549[ISI][Medline]
-
Sugimoto M, Oohashi T, Ninomiya Y. The genes COL4A5 and COL4A6, coding for basement membrane collagen chains alpha 5(IV) and alpha 6(IV), are located head-to-head in close proximity on human chromosome Xq22 and COL4A6 is transcribed from two alternative promoters. Proc Natl Acad Sci USA1994; 91: 1167911683[Abstract/Free Full Text]
-
Oohashi T, Sugimoto M, Mattei MG, Ninomiya Y. Identification of a new collagen IV chain, alpha 6(IV), by cDNA isolation and assignment of the gene to chromosome Xq22, which is the same locus for COL4A5. J Biol Chem1994; 269: 75207526[Abstract/Free Full Text]
-
Srivastava AK, Featherstone T, Wein K, Schlessinger D. YAC contigs mapping the COL4A5 and COL4A6 genes and DXS118 within Xq21.3-q22. Genomics1995; 26: 502509[ISI][Medline]
Received for publication: 15. 5.01
Revision received 19. 7.01.